RU2406469C2 - Method of treating dystrophic diseases of retina and optic nerve - Google Patents

Abstract

FIELD: medicine.

SUBSTANCE: invention refers to medicine, namely to ophthalmology, and aims at treating dystrophic diseases of retina and optic nerve. A diagnostic vegetative resonance test (VRT) is administered with the 'Imedis' hardware-software complex 'Expert-Fol'. Electric bioelectric potentials in a reproduced BAP are recorded, and simultaneously an eye is exposed to bipolar impulses supplied by a magnetic inductor of this apparatus. The frequency values 7.0; 19.5; 19.75; 50.0; 50.5; 93.5; 65.5; 74.5; 79.5; 93.5; 94.5 Hz are applied. The frequencies not reaching 80 standard units are detected. Then patient's palms and feet are placed on 'hand' and 'foot' bioresonance therapy (BRT) electrode plates for, while a 'frontal' BRT-electrode plate is fixed on an eyeball. The 'frontal' electrode plate is covered with a magnetic inductor connected to a magnetotherapy socket. Further, exposure to the detected electromagnetic frequencies follows for 2 minutes and more to ensure the electric values of a reference of 80 standard units in the reproduced BAP. The therapeutic course is 7-10 daily sessions. Right after the procedures, pharmacotherapy is administered to intensify the functional activity of nerve cells.

EFFECT: method allows better hemodynamics in retina and optic nerve and capillary perfusion with improved drug delivery.

1 tbl, 2 ex

Description

The invention relates to medicine, namely to ophthalmology, and can be used to treat degenerative diseases of the retina and optic nerve.

In recent years, there has been a steady tendency towards an increase in the frequency of dystrophic diseases of the optic nerve and retina, leading to low vision and irreversible blindness in people of different ages. A significant role in the etiopathogenesis of this severe ophthalmopathology is played by general and local vascular disorders that worsen the level of capillary perfusion and trophic processes in the optic-nervous apparatus of the eye (Kiseleva T.N., Polunin G.S., Eliseeva E.G. et al. Modern aspects of pathogenesis and clinic of age-related macular degeneration / Ophthalmology, 2005, Vol. 2, No. 1, pp. 18-24; Neroev V.V., Malinovskaya T.A., Ivanov A.N. et al. New possibilities in the treatment of involutional central chorioretinal dystrophy (CHRD) / Ophthalmology, 2005, Vol. 2, No. 1, pp. 53-56; Klyuev G.O. and oavt. plazmatsitofereza Influence on rheological properties of blood and ocular hemodynamics in patients with acute and chronic vascular optikoneyropatiyami / ophthalmia. Well -n 2008, №1, s.54-59, etc.).

There are methods of treating degenerative diseases of the retina and optic nerve using numerous pharmacological agents: vasodilating drugs, nootropic drugs, bioregulators, antihypoxants, antioxidants, etc.

The disadvantages of this method are:

- the impossibility of creating a therapeutic concentration of drugs, for example, aminalon and other derivatives of gamma-aminobutyric acid in the tissues of the eye due to the presence of an isolated blood-phthalmic barrier and, therefore, the low efficiency of the method (MD Mashkovsky. Medicines (13th edition) 2 volumes, T.1. - Kharkov “Torsing”, 1998, p.111);

- increased drug load - the need for vasodilator drugs in combination with other medicinal products in order to increase their penetration into the nerve cells of the eye, because the main way the substance moves into the nerve cell is hematogenous - through the walls of the capillary (Human Physiology: Textbook / In 2 vols. T.1. / Edited by V. M. Pokrovsky and G. F. Korotko. - M .: Medicine , 1998. - p. 126-128);

- the risk of a drop in perfusion pressure in the intraocular vessels with the introduction of vasodilating drugs, contributing to the deterioration of the metabolism of eye structures (Krasnov M.M.Glaucoma Microsurgery. 2nd edition / USSR Academy of Medical Sciences. - M .: Medicine, 1980, p.22; Egorov V. V., Smolyakova G.P., Luzyanina V.V. Glaucoma (study guide), Khabarovsk: Publishing House Center IPKSZ, 2005, p. 92);

- lack of individualization of treatment for each patient;

- the risk of complications, allergic reactions.

There are also physiotherapeutic methods for treating degenerative diseases of the retina and optic nerve, which contribute to the improvement of hemodynamic parameters of the eye: electrophoresis of vasodilator drugs, ultrasound therapy, laser therapy, microwave therapy, etc.

The disadvantages of these methods are:

- low efficiency and short duration of the result of exposure (Ponomarchuk BC, Gurtovaya O.V., Savko V.V. Influence of ultrasound and pulsed electromagnetic field on the functions of the visual system and hemodynamics of the eye in patients with age-related macular degeneration depending on the severity of the pathological process / Ophthalm. -l, 2007, No. 2, p. 38-41);

- lack of individualization of exposure;

- lack of information on the influence of physical factors on the pharmacological activity of many drugs used in the treatment of patients with degenerative diseases of the retina and optic nerve;

- a large number of contraindications;

- the difficulty in choosing the optimal drug that is injected into the eye with the help of physical factors, if there is no special diagnostic equipment - devices for electropuncture diagnostics according to the method of R. Voll or VRT (autonomic resonance test);

- the lack of correction of the therapy during the session;

- the risk of drug allergies and intolerance to the physical factor.

The prototype of the method is a magnetotherapy method in combination with drug treatment by using an apparatus, for example, AMO-ATOS, generating a traveling pulsed magnetic field (Newspaper Okulist, 2004, No. 12 (66)).

The disadvantages of the method are:

- insufficient treatment effectiveness;

- lack of adequate regulation of homeostatic equilibrium of the body;

- lack of individualization of exposure;

- lack of the possibility of correction of ongoing therapy in the treatment process;

- lack of information on the influence of the magnetic field on the pharmacological activity of many drugs used to treat patients with this eye pathology - bioregulators, nootropic substances, antioxidants, etc .;

- the risk of intolerance to the magnetic field - severe arterial hypotension (operating instructions for the device "AMO-ATOS"), which can lead to a drop in perfusion pressure in the intraocular vessels (Krasnov MM Glaucoma Microsurgery. 2nd edition / USSR Academy of Medical Sciences. - M .: Medicine, 1980, p.22) and worsen trophic tissue.

The objective of the invention is to provide a method for improving the quality of treatment of patients with degenerative diseases of the retina and optic nerve.

The technical result is to increase the efficiency of treatment of patients with degenerative diseases of the retina and optic nerve by improving hemodynamics in the retina, optic nerve and capillary perfusion with an increase in the delivery of drugs that enhance the functional activity of nerve cells.

The technical result is achieved by the fact that patients with dystrophic diseases of the retina and optic nerve undergo adaptive bioresonance therapy (BRT) in combination with frequency electromagnetic therapy on the Expert-Voll hardware-software complex of Imedis firm (Russia, Moscow) (Meizerov E. E, Blinkov I.L., Gotovsky Yu.V. et al. Bioresonance therapy: a methodical recommendation. M: Scientific and Practical Center for Traditional Medicine and Homeopathy. MH RF, 2000. - 27 p .; Gotovsky Yu. .V., Kosareva LB, Blinkov I.L., Samokhin A.V. Exogenous bioresonance therapy iksirovannymi frequencies -. Moscow, "IMEDIS", 2001. -. 96 seconds), after which selected administered pharmacological agents. The choice of treatment tactics is carried out in accordance with the results of electropunctural diagnostics by the method of autonomic resonance test (ART) (Gotovsky Yu.V., Kosareva LB, Makhonkina LB, Sazonova IM, Frolova LA, Gritsenko EG Electropuncture diagnostics and therapy using the Imedis-test, a resonance test (Methodical recommendations). - M .: Imedis, 2000, 150 pp.).

Preliminarily, using the ART method, each patient is selected the frequencies of electromagnetic oscillations of R. Voll, P. Schmidt, R. Rife, listed in the apparatus database, aimed at improving capillary perfusion: using the probe of the apparatus, biopotentials are recorded at a reproducible biologically active point (BAP), t .e. point, during repeated measurement of which the same measured values are obtained by the pumping method. - 80 at e. At the same time, they affect the eye with bipolar pulses supplied from the magnetic inductor of the device, with frequencies of vascular-trophic action - 7.0; 19.5; 19.75; 50.0; 50.5; 93.5 Hz; as well as frequencies that improve the function of the optic nerve - 79.5; 93.5; 94.5 Hz and a retina of 65.5; 74.5 Hz. Those values of the reproducible BAP biopotentials that do not reach the norm of 80 cu on the measuring scale of the device, used in treatment.

The therapy is carried out as follows: the patient’s bare palms and feet are placed on the plate “hand” and “foot” electrodes, the “frontal” electrode is fixed on the eyeball. The electrodes are connected to the corresponding sockets of the apparatus for BRT. A magnetic inductor connected to a magnetotherapy socket is placed on top of the “frontal” electrode. BRT and frequency electromagnetic therapy are performed simultaneously. The duration of exposure to each frequency is 2 minutes or more, depending on the ART indicators - until the electrical indicators of the reproduced BAT are restored. If the electrical indicators on the reproducible BAP, when exposed to an eye of a certain frequency, return to normal - 80 cu, then this frequency is not used during therapy.

The BRT course consists of 7-10 daily sessions. Immediately after the end of the BRT session, well-tolerated drugs that are paraorbitally selected using the VRT method are administered.

The advantages of the proposed method:

- reducing the recovery time of capillary perfusion and hemodynamics of the eye with degenerative diseases of the retina and optic nerve;

- the ability to adequately regulate the homeostatic equilibrium of the body, including in the blood-brain barrier control system, through the use of adaptive bioresonance therapy on the Expert-Fall apparatus of the Imedis company, which is capable of isolating and damping pathological electromagnetic oscillations generated by the human body or its pathological body;

- individualization of therapy;

- the possibility of individual selection of electromagnetic frequencies during therapy and selection of the most effective and well-tolerated drugs and their therapeutic doses for each patient;

- the possibility of correction of ongoing therapy during each session;

- good tolerability of treatment;

- the absence of complications, allergic reactions.

Table Comparative analysis of the therapeutic effectiveness of the use of bioresonance therapy and magnetotherapy in the complex treatment of patients with degenerative diseases of the retina and optic nerve Categories of patients Total Patients (n) Comprehensive Treatment Results n bioresonance therapy n magnetotherapy improve. no change improve. no change Age-related macular degeneration: 28 fifteen 13 2 13 8 5 - initial stage 8 8 - 7 - one - advanced stage 5 four one four - 2 - far-reaching stage 2 one one 2 - 2 Atrophy of the optic nerve: thirty 17 fourteen 3 13 7 6 - beginning stage 8 8 - 7 5 2 - advanced stage 7 6 one 5 2 3 - far stage 2 - 2 one - one Total patients: 58 32 27 5 26 fifteen eleven Note: an improvement in the initial stage of the dystrophic process in the retina and optic nerve is considered to be an increase in visual acuity after treatment of more than 0.1; with a developed stage - by 0.05-0.1; at the advanced stage - by 0.01-0.04.

As follows from the table, after complex treatment using bioresonance therapy, the number of patients with an improvement in visual function with dystrophy of the retina and optic nerve increased almost 2 times compared with the use of magnetotherapy. At the same time, the average degree of increase in visual acuity in patients with age-related macular degeneration and optic atrophy during bioresonance therapy was 0.33, and magnetotherapy - 0.21.

Example 1. Patient K., 62 years old, is observed at the ophthalmologist in the clinic at the place of residence with a diagnosis of age-related macular degeneration of both eyes. Received in HF FSI MNTK "Eye Microsurgery" for a course of conservative therapy. An examination revealed a decrease in visual acuity of the right eye to 0.2, the left to 0.3. Appointed: daily intravenous mexidol 5% solution of 2.0 ml, parabulbar cerebrolysin 1.0 ml and magnetotherapy on the device "AMO-ATOS", generating a traveling pulsed magnetic field. After 10 days of treatment, visual acuity indicators remained the same.

After 1 month, the course of treatment was repeated and included adaptive BRT with exposure to the eye of bipolar pulses from the magnetic inductor of the Imedis-Voll apparatus with the chosen frequency of vascular-trophic action - 7.0; 19.75; 50.5; 93.5 Hz and frequencies that improve the function of the retina - 65.5; 74.5 Hz before the restoration of electrical indicators corresponding to the norm - 80 cu, in reproducible BAT. Immediately after this, 1.0 ml of cerebrolysin was administered parabulbarly. After 10 sessions of this treatment, the visual acuity of the right eye increased to 0.4, the left eye to 0.6. The achieved functional result remained stable for 4 months.

Example 2. Patient S., 44 years old. After a traumatic brain injury, post-traumatic downward atrophy of the optic nerves of both eyes developed with a decrease in visual acuity of the right eye to 0.5, the left to 0.2. Within 8 months after the injury, he was observed and treated for the pathology of the optic nerves at the ophthalmologist at the community clinic. Despite the treatment, the visual acuity of both eyes remained the same without a tendency to improve. To conduct the next course of treatment, he applied to the HF FSI MNTK “Eye Microsurgery”. The patient was prescribed adaptive BRT and frequency electromagnetic therapy by exposing the eye to bipolar pulses from the magnetic inductor of the device with frequencies of vascular trophic action - 7.0; 19.5; 50.0; 93.5 Hz, and frequencies that improve the function of the optic nerve -79.5; 94.5 Hz, selected for this patient using the ART method for electropuncture diagnostics. The impact was carried out before the restoration of the electrical indicators of the reproduced BAT, corresponding to the norm - 80 cu Immediately after this, 1.0 ml of cerebrolysin was administered parabulbarly. 10 days after this treatment, the visual acuity of the right eye increased to 0.7, the left - to 0.4. The achieved functional result remained stable for 3 months.

Claims (1)

A method for the treatment of dystrophic diseases of the retina and optic nerve, consisting in the use of electromagnetic waves, characterized in that on the hardware-software complex "Expert-Fol" of the company "Imedis" conduct a diagnostic autonomic resonance test (ART), registering electrical biopotentials in reproducible BAT with simultaneous the influence of bipolar pulses on the eye, supplied from the magnetic inductor of this device, use frequency - 7.0; 19.5; 19.75; 50.0; 50.5; 93.5; 65.5; 74.5; 79.5; 93.5; 94.5 Hz, frequencies that do not reach - 80 cu are detected, then the patient’s palms and feet are placed on the plate “hand” and “foot” electrodes for bioresonance therapy - BRT, and the “frontal” electrode for BRT is fixed on an eyeball, on top of the “frontal” electrode there is a magnetic inductor connected to the magnetotherapy socket, then they are exposed to the detected electromagnetic frequencies from 2 or more minutes to obtain electrical indicators in the reproduced BAT, corresponding to the norm - 80 cu, a course of 7- 10 daily sessions, immediately after the procedure, they carry out therapy with drugs that enhance the functional activity of nerve cells.